Hefei Tianmai Biotechnology Development

About Hefei Tianmai Biotechnology Development

Hefei Tianmai Biotechnology Development Co.Ltd. ("HTBT"), a subsidiary of Hefei Life Science, has established an advanced manufacturing plant in accordance with European standards and has successfully developed recombinant human insulin. HTBT is in the process of developing insulin analogues and plans to sell the products around the world.

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
Oceania
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

CN
2017

On CPHI since

Compare

Add to favorites Added to favorites

Company types

Manufacturer/Innovator

Contact info

+86 010-58036292
Website
Co., Ltd, 199 Fanhua Road, Hefei Economic and Techological, Development Zone, 230601, Anhui, China

CPHI Online is the largest global marketplace in the pharma ingredients industry

Hefei Tianmai Biotechnology Development

About Hefei Tianmai Biotechnology Development

Sales Markets

Position your company at the heart of the global Pharma industry with a CPHI Online membership

Coming soon

Hefei Tianmai Biotechnology Development

Address

Telephone

Website

Request for general information

Send a message to Please review your profile details to ensure it is up-to-date.

Send a message to
Please review your profile details to ensure it is up-to-date.